Prognostic marker analysis in pediatric posterior fossa ependymomas.

Journal Article (Journal Article)

NELL2 expression has been shown to identify patients with posterior fossa ependymomas (PFEp) that exhibit prolonged survivals. We analyzed expression NELL2; KI-67; Tenascin C; CD34; VEGF; and CA IX as well as vascular density against post-operative survival (Progression Free and Overall Survival; PFS, OS) in 31 patients under the age of 22 years.

Full Text

Duke Authors

Cited Authors

  • McLendon, RE; Lipp, E; Gururangan, S; Fuchs, H; Zagzag, D; Herndon, J; Healy, P

Published Date

  • July 2014

Published In

Volume / Issue

  • 16 Suppl 3 /

Start / End Page

  • iii27 -

PubMed ID

  • 25165266

Pubmed Central ID

  • PMC4144561

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

Digital Object Identifier (DOI)

  • 10.1093/neuonc/nou208.17


  • eng

Conference Location

  • England